Ginsenosides Rk1, Rg5, Rk3, and Rh4 can significantly reduce the target proteins NLRP3, ASC, and caspase-1 of AD in BV-2 cells by inhibiting inflammasome signaling. This evidence concerns the gene NLRP3 and Alzheimer disease.